Fund code: 4061

  • NAV
    $19.50 -$0.05 / -0.27%
    05-Jun-2023
  • Inception 14-Jun-2018
  • Benchmark 50% S&P 500 Index – Hedged CAD 50% MSCI World Small Cap Index – Hedged CAD
  • Aggregate assets
    (all series)
    $130.5M
    31-May-2023
  • MER 2.26%
    30-Nov-2022
  • Distributions
  • Morningstar category Global Equity
  • Also available through: Class US$, Class CDN$ and Class Currency Neutral T-Series S5
  • Get Fund Facts

End investment

Annualized return

Choose a chart type (percentage or dollar)
Choose a predefined chart period
to:

Start NAV

$10.0000

End NAV

$10.4031
Choose a predefined chart period
to:

Calendar returns (%) 31-May-2023

YTD 2023 2022 2021 2020 2019
Fund 7.12 -16.23 19.92 13.65 22.62

Standard period returns (%) 31-May-2023

1 mo 3 mo 6 mo 1 yr 3 yr Inception
Fund -0.44 2.37 2.44 2.11 8.99 5.33

Why invest in this fund?

  • A core diversified equity strategy that seeks to invest in the most compelling opportunities across the globe.
  • Provides exposure to both growth and value investment styles, as well as a range of company sizes and regions, with the aim of achieving strong risk-adjusted returns.
  • Managed by two of Fidelity’s most successful portfolio managers and backed by Fidelity’s global research platform.

Risk measures (%) 30-Apr-2023

Fund
Annualized standard deviation 15.13
Beta 0.86
0.97

Risk classification

  1. Low
  2. Low to medium
  3. Medium
  4. Medium to high
  5. High

This fund has a medium volatility rating

Allocation

Asset mix (%)

30-Apr-2023

Country mix (%)

30-Apr-2023

Sector mix (%)

30-Apr-2023
12 months ago Last month Current month
Information Technology 18.2 16.4 16.1
Health Care 14.3 14.5 14.8
Financials 16.6 14.1 13.4
Industrials 9.3 12.7 12.9
Consumer Disc. 11.8 11.0 11.3
Energy 4.3 7.7 7.6
Communication Services 7.3 7.4 7.6
Materials 6.0 6.0 5.4
Consumer Staples 5.2 4.5 4.5
Utilities 0.9 1.0 1.0
Real Estate 1.1 0.1 0.1

Top ten holdings

  1. META PLATFORMS INC CL A
  2. Apple
  3. UnitedHealth Group
  4. Berkshire Hathaway, Cl. B
  5. Microsoft
  6. Nvidia
  7. Regeneron Pharmaceuticals
  8. Amazon.com
  9. Eli Lilly
  10. ALPHABET INC CL A
Total number of holdings 764
Top ten holdings aggregate 19.5%
  1. UnitedHealth Group
  2. Berkshire Hathaway, Cl. B
  3. Apple
  4. META PLATFORMS INC CL A
  5. Regeneron Pharmaceuticals
  6. Microsoft
  7. Eli Lilly
  8. Amazon.com
  9. ALPHABET INC CL A
  10. Vertex Pharmaceuticals
Total number of holdings 758
Top ten holdings aggregate 18.1%
  1. UnitedHealth Group
  2. Apple
  3. Berkshire Hathaway, Cl. B
  4. META PLATFORMS INC CL A
  5. Amazon.com
  6. Microsoft
  7. ALPHABET INC CL A
  8. Regeneron Pharmaceuticals
  9. Eli Lilly
  10. Vertex Pharmaceuticals
Total number of holdings 778
Top ten holdings aggregate 20.2%
  1. UnitedHealth Group
  2. Apple
  3. META PLATFORMS INC CL A
  4. Berkshire Hathaway, Cl. B
  5. Microsoft
  6. ALPHABET INC CL A
  7. Eli Lilly
  8. Amazon.com
  9. Regeneron Pharmaceuticals
  10. Nvidia
Total number of holdings 800
Top ten holdings aggregate 19.1%
View all